BR9700196B8 - dispositivo e método para a remoção extracorpórea de toxinas, em particular citoquinas, especialmente para o tratamento de pacientes afetados por insuficiência orgânica aguda - Google Patents

dispositivo e método para a remoção extracorpórea de toxinas, em particular citoquinas, especialmente para o tratamento de pacientes afetados por insuficiência orgânica aguda

Info

Publication number
BR9700196B8
BR9700196B8 BRPI9700196A BR9700196A BR9700196B8 BR 9700196 B8 BR9700196 B8 BR 9700196B8 BR PI9700196 A BRPI9700196 A BR PI9700196A BR 9700196 A BR9700196 A BR 9700196A BR 9700196 B8 BR9700196 B8 BR 9700196B8
Authority
BR
Brazil
Prior art keywords
ultrafiltrate
toxins
treatment
plasmafiltrate
organ failure
Prior art date
Application number
BRPI9700196A
Other languages
English (en)
Other versions
BR9700196B1 (pt
BR9700196A (pt
Inventor
Tetta Ciro
Lou Wratten Mary
Original Assignee
Bellco Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8225805&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9700196(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bellco Spa filed Critical Bellco Spa
Publication of BR9700196A publication Critical patent/BR9700196A/pt
Publication of BR9700196B1 publication Critical patent/BR9700196B1/pt
Publication of BR9700196B8 publication Critical patent/BR9700196B8/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3616Batch-type treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Cardiology (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

patente de invenção "dispositivo e método para a remoção extracorpórea de toxinas, em particular citoquinas, especialmente para o tratamento de pacientes afetados por insuficiência orgânica aguda" preve que a remoção efetiva das citoquinas é realizada por uma primeira submissão do sangue a purificação por ultrafiltragem ou plasmafiltragem; subsequentemente alimentando o ultrafiltrado ou plasmafiltrado através de uma coluna de adsorção na qual o material adsorvente é o carbono ativado não recoberto e/ou resinas de poliestireno hidrofóbicas ou trocadoras de íons, tais como amberlite (mr), amberchrom (mr) ou ambersorb (mr); e então adicionando o ultrafiltrado ou plasmafiltrado purificado ao eluato recuperado a juzante do ultrafiltrado ou plasmafiltro; preferencialmente o ultrafiltrado ou plasmafiltrado é submetido a uma dupla fase de adsorção, primeiro através de uma coluna de carbono ativado e então através de uma coluna contendo resinas hidrofóbicas ou de troca iônica.
BRPI9700196A 1996-02-06 1997-02-05 dispositivo e método para a remoção extracorpórea de toxinas, em particular citoquinas, especialmente para o tratamento de pacientes afetados por insuficiência orgânica aguda BR9700196B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96830049A EP0787500B1 (en) 1996-02-06 1996-02-06 Device for extracorporeal removal of toxins, in particular cytokines

Publications (3)

Publication Number Publication Date
BR9700196A BR9700196A (pt) 1998-09-29
BR9700196B1 BR9700196B1 (pt) 2014-03-18
BR9700196B8 true BR9700196B8 (pt) 2021-06-22

Family

ID=8225805

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9700196A BR9700196B8 (pt) 1996-02-06 1997-02-05 dispositivo e método para a remoção extracorpórea de toxinas, em particular citoquinas, especialmente para o tratamento de pacientes afetados por insuficiência orgânica aguda

Country Status (7)

Country Link
EP (2) EP0787500B1 (pt)
CN (1) CN1159951A (pt)
AR (1) AR005728A1 (pt)
BR (1) BR9700196B8 (pt)
DE (2) DE69605395T2 (pt)
ES (2) ES2141462T3 (pt)
GR (1) GR3032624T3 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6620382B1 (en) * 1998-05-22 2003-09-16 Biopheresis Technologies, Llc. Method and compositions for treatment of cancers
US6287516B1 (en) * 1998-07-10 2001-09-11 Immunocept, L.L.C. Hemofiltration systems, methods, and devices used to treat inflammatory mediator related disease
US6774102B1 (en) 1999-09-29 2004-08-10 Gambro Dialysatoren Gmbh & Co. Kg Extracorporeal endotoxin removal method
US6736972B1 (en) 2000-03-24 2004-05-18 Immunocept, L.L.C. Method and system for providing therapeutic agents with hemofiltration for reducing inflammatory mediator related diseases
US8535258B2 (en) 2000-03-24 2013-09-17 Immunocept, L.L.C. Hemofiltration methods for treatment of diseases in a mammal
US7291122B2 (en) * 2000-03-24 2007-11-06 Immunocept, L.L.C. Hemofiltration methods for treatment of diseases in a mammal
US8597516B2 (en) 2000-05-16 2013-12-03 Immunocept, L.L.C. Methods and systems for colloid exchange therapy
US6787040B2 (en) 2000-05-16 2004-09-07 Immunocept, L.L.C. Method and system for colloid exchange therapy
DE10118446A1 (de) * 2001-04-12 2002-10-17 Thomas Hartung Prüfverfahren zur Untersuchung fließfähiger Medien auf Gehalte an mikrobiellen Toxinen
WO2003009885A2 (en) * 2001-07-25 2003-02-06 Immunocept, L.L.C. Hemofiltration systems, methods and devices used to treat inflammatory mediator related disease
US20040228829A1 (en) * 2003-03-11 2004-11-18 Roberts Craig P. Plasma detoxification system and methods of use
US8038638B2 (en) 2004-02-23 2011-10-18 Hemolife Medical, Inc. Plasma detoxification and volume control system and methods of use
GB0408521D0 (en) * 2004-04-16 2004-05-19 Carbon Technologies Nv Treatment of sepsis
JP2008503273A (ja) 2004-06-21 2008-02-07 ヘモライフ メディカル, インコーポレイテッド 血漿無毒化および体積制御システムならびに使用方法
US8339447B2 (en) 2004-10-21 2012-12-25 Truevision Systems, Inc. Stereoscopic electronic microscope workstation
DE102004054747A1 (de) * 2004-11-12 2006-05-24 Fresenius Medical Care Deutschland Gmbh Verfahren und Vorrichtung zur Abreicherung wenigstens einer Komponente eines fluiden Mediums
KR100972702B1 (ko) * 2005-03-31 2010-07-27 도레이 카부시키가이샤 흡착재 및 체외 순환용 칼럼
ATE477009T1 (de) * 2007-01-12 2010-08-15 Bellco Srl Kit zur behandlung von erkrankungen im zusammenhang mit systemischen entzündungen
US8672869B2 (en) 2007-10-30 2014-03-18 Bellco S.R.L. Kit, system and method of treating myeloma patients
JP5249737B2 (ja) * 2008-12-10 2013-07-31 旭化成メディカル株式会社 血液からウイルス及びサイトカインを除去するシステム
US20130256227A1 (en) * 2011-09-12 2013-10-03 Medtronic, Inc. Polystyrene sulfonate resin for use with a hemodialysis system having a controlled compliance dialysis circuit
EP2679302A1 (de) 2012-06-28 2014-01-01 Zentrum für biomedizinische Technologie der Donau- Universität Krems Selektives Sorptionsmittel für die extrakorporale Blutreinigung
CN103223197A (zh) * 2013-04-23 2013-07-31 天津市阳权医疗器械有限公司 用于毒血症血液净化的医疗器械组合装置
WO2014209782A1 (en) * 2013-06-24 2014-12-31 Exthera Medical Corporation Blood filtration system containing mannose coated substrate
CN106659834B (zh) 2014-08-26 2019-06-18 3M创新有限公司 用于去除血液中的促炎介质以及粒细胞和单核细胞的系统
PE20220165A1 (es) 2019-01-11 2022-01-28 Marker Holdings Ag Metodos y sistemas de desintoxicacion de plasma

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2722025A1 (de) * 1977-05-16 1978-11-30 Hoechst Ag Membraneinheit, vorrichtung mit membraneinheit und verfahren zur blutreinigung
AU5522390A (en) * 1989-04-19 1990-11-16 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Process for removing c-reactive protein and anti-phosphorylcholine antibodies from biological fluids
IT1241588B (it) * 1990-03-09 1994-01-19 Sorin Biomedica Emodialisi S R Apparecchiatura per la depurazione del sangue, particolarmente per il trattamento di pazienti affetti da insufficienza renale, e procedimentoo per produzione di liquido di reinfusione per emodiafiltrazione (hdf)
JP3276456B2 (ja) * 1993-04-28 2002-04-22 旭メディカル株式会社 エンドトキシン及び/又はサイトカインの吸着材及び該吸着材を用いた浄化血液の取得装置

Also Published As

Publication number Publication date
AR005728A1 (es) 1999-07-14
CN1159951A (zh) 1997-09-24
EP0958839A2 (en) 1999-11-24
DE69634141D1 (de) 2005-02-03
GR3032624T3 (en) 2000-05-31
EP0787500A1 (en) 1997-08-06
BR9700196B1 (pt) 2014-03-18
ES2141462T3 (es) 2000-03-16
DE69634141T2 (de) 2005-12-22
BR9700196A (pt) 1998-09-29
EP0958839B1 (en) 2004-12-29
EP0787500B1 (en) 1999-12-01
EP0958839A3 (en) 1999-12-15
ES2234183T3 (es) 2005-06-16
DE69605395D1 (de) 2000-01-05
DE69605395T2 (de) 2000-06-08

Similar Documents

Publication Publication Date Title
BR9700196B8 (pt) dispositivo e método para a remoção extracorpórea de toxinas, em particular citoquinas, especialmente para o tratamento de pacientes afetados por insuficiência orgânica aguda
US5679260A (en) Process for simultaneously removing tumour necrosis factor α and bacterial lipopolysaccharides from an aqueous liquid
ATE195891T1 (de) Sorbentmittel und dessen herstellungsverfahren
AU580402B2 (en) Method of inactivating viruses involving adsorption on solid phase
WO2002043859A2 (en) Cartridges useful in cleaning dialysis solutions
JPH08299436A (ja) 全血及び/又は血漿から腫瘍壊死因子α及び細菌性リポ多糖類を同時体外除去する方法及び装置
Yamamoto et al. Adsorption of protein‐bound uremic toxins through direct hemoperfusion with hexadecyl‐immobilized cellulose beads in patients undergoing hemodialysis
EP0276376A3 (en) A system for the preparation of a fluid intended for a medical treatment
Geiger et al. Biochemical assessment and clinical evaluation of a bilirubin adsorbent column (BR-350) in critically ill patients with intractable jaundice
Botella et al. Adsorption in hemodialysis
Reynier et al. A continuous hemofiltration system using sorbents for hemofiltrate regeneration
Man et al. Uremic neurotoxin in the middle molecular weight range
GB1406133A (en) Adsorbent for recycling type artificial kidney
BR9712167A (pt) Processo de purificação de uma toxina de polissacarìdeo das bactérias gbs, toxina das bactérias gbc, composição farmacêutica, e, processos de tratamento de um paciente tendo uma condição médicae com um tumor.
EP1078911A3 (de) Verfahren zum Feinreinigen einer wässrigen Lösung, die eine fermentativ hergestellte organische Säure enthält
KR960040358A (ko) 초항원 제거 또는 해독용 재료
KR100752414B1 (ko) Psaf 인공 간 시스템
JPS5758629A (en) Separating and purifying method of colonization stimulating factor and callicrein in human urine
WO2024053363A1 (ja) 対象液浄化装置および対象液浄化方法
Gurland et al. Sorbent membranes used in a conventional dialyzer format: In vitro and clinical evaluation
Bosch et al. Overview: techniques and indications of LDL-apheresis
JPH07284531A (ja) 血液中の毒性物質除去装置
Anelli et al. Beta-2-Microglobulin (B2m) Adsorption on Activated Charcoal (AC)
RU2163140C1 (ru) Концентрат фактора ix системы свертывания крови и способ его получения
Walther et al. On the adsorption treatment of wastewaters of a pharmaceutical enterprise.

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/03/2014, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 24A ANUIDADE.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/02/1997, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2616 DE 23-02-2021 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 06/02/2017